Aldhaeefi, M.; Beers, B.; Shah, J.; Rizi, S.S.; Rungkitwattanakul, D.; Nimoh, O.; Frimpong, V.; Gonzalez, J.; Belrhiti, S.; Urooj, F.;
et al. Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy. Pharmacy 2023, 11, 58.
https://doi.org/10.3390/pharmacy11020058
AMA Style
Aldhaeefi M, Beers B, Shah J, Rizi SS, Rungkitwattanakul D, Nimoh O, Frimpong V, Gonzalez J, Belrhiti S, Urooj F,
et al. Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy. Pharmacy. 2023; 11(2):58.
https://doi.org/10.3390/pharmacy11020058
Chicago/Turabian Style
Aldhaeefi, Mohammed, Brandon Beers, Jenny Shah, Saba Saeidi Rizi, Dhakrit Rungkitwattanakul, Oliver Nimoh, Victoria Frimpong, Jackie Gonzalez, Sanaa Belrhiti, Fatima Urooj,
and et al. 2023. "Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy" Pharmacy 11, no. 2: 58.
https://doi.org/10.3390/pharmacy11020058
APA Style
Aldhaeefi, M., Beers, B., Shah, J., Rizi, S. S., Rungkitwattanakul, D., Nimoh, O., Frimpong, V., Gonzalez, J., Belrhiti, S., Urooj, F., & Williams, D.
(2023). Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy. Pharmacy, 11(2), 58.
https://doi.org/10.3390/pharmacy11020058
